The Trend in Morning Levels of Salivary Cortisol in Children With ADHD During 6 Months of Methylphenidate Treatment.
Wang, Liang-Jen; Huang, Yu-Shu; Hsiao, Cheng-Cheng; Chen, Chih-Ken.
J Atten Disord
; 21(3): 254-261, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-23223012
New stimulant formulations for pediatric attention-deficit/hyperactivity disorder: a case-based approach for the primary care provider.
Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.
Driving and attention deficit hyperactivity disorder.
The Improvement of Individually Defined Problem Behaviors During a Telephone-Assisted Self-Help Intervention for Parents of Pharmacologically Treated Children with ADHD.
A multicentre randomized controlled trial on trans-generational attention deficit/hyperactivity disorder (ADHD) in mothers and children (AIMAC): an exploratory analysis of predictors and moderators of treatment outcome.
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years.
Methylphenidate for children and adolescents with autism spectrum disorder.